Huan Xu,Qing Chang,Yuan Zong
Huan Xu
Robert Chung,Brittany Powell,Scott McClatchey
Robert Chung
Faricimab for High-Need Aflibercept 2 mg Treated Neovascular Age-Related Macular Degeneration [0.03%]
远视图用于阿柏西普治疗效果不佳的湿性年龄相关性黄斑变性的疗效和安全性评估：III期随机临床试验
Monja Michelitsch,Regina Riedl,Sanja Strini et al.
Monja Michelitsch et al.
Purpose: To assess whether "high-need" treated neovascular age-related macular degeneration (nAMD) eyes, requiring aflibercept 2 mg every 3-5 weeks, can be extended in their treatment interval when switched to faricimab. ...
Serous Retinopathy with Focal Retinal Pigment Epithelium Elevations after Panretinal Photocoagulation [0.03%]
全视网膜激光光凝治疗后的以脉络膜渗漏和局部的色素上皮脱离为特征的渗出性视网膜病变
Paolo Forte,Alberto Quarta,Srinivas R Sadda
Paolo Forte
Features of the Vitreoretinal Interface in Snowflake Vitreoretinal Degeneration [0.03%]
雪片状玻璃膜变性的眼底至玻璃体界面的特征化研究
Yarou Hu,Kaixuan Cui,Guoming Zhang
Yarou Hu
Manu Sharma,Atul Arora,Vishali Gupta
Manu Sharma
Transient Optical Coherence Tomography Changes after High-Dose Intravitreal Topotecan for retinoblastoma: case series [0.03%]
高压态光学 coherence 技术对视网膜母细胞瘤的治疗影响：病例系列报告
Christina Stathopoulos,Francis L Munier
Christina Stathopoulos
Purpose: To report and describe transient spectral-domain OCT (SD-OCT) changes following high-dose intravitreal topotecan (HD-IvitTopo) in retinoblastoma patients. ...
Incidence, Timing, and Management of Postoperative Tilt with the Yamane Technique for Secondary IOL Implantation or Reposition [0.03%]
Yamane技术二期人工晶状体植入或复位术后倾斜的发生率、时间及处理
Hueyjong Shih,Pooja P Patel,Celine Chaaya et al.
Hueyjong Shih et al.
Purpose: To evaluate the incidence, timing, and management of postoperative intraocular lens (IOL) tilt following secondary IOL implantation or repositioning using the Yamane flanged intrascleral haptic fixation (FISHF) t...
Development and Validation of Simple Clinical and OCT-Based Prognostic Scores for Visual Outcomes in Branch Retinal Vein Occlusion [0.03%]
简单临床和OCT基于预后评分在分支视网膜静脉阻塞中的发展和验证以预测视力结局
Hiroki Sano,Ryoji Yanai,Hirotaka Kondo et al.
Hiroki Sano et al.
Objective: This study aimed to develop and externally validate simple, clinically interpretable scoring systems for predicting 12-month visual outcomes in eyes with branch retinal vein occlusion (BRVO), and to evaluate wh...